19.70
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News
Kiniksa Pharmaceuticals International Plc (KNSA) Stock: Tracking the Weekly Performance - The News Heater
Is Kiniksa Pharmaceuticals International Plc (KNSA) a opportunity to investors? - US Post News
Keeping an Eye on Kiniksa Pharmaceuticals International Plc (KNSA) After Insider Trading Activity - Knox Daily
Stock Market Recap: Kiniksa Pharmaceuticals International Plc (KNSA) Concludes at 18.88, a -3.67 Surge/Decline - The Dwinnex
Exploring High Growth Tech Stocks in the United States - Simply Wall St
Kiniksa Pharmaceuticals Reports Strong 2024 Financial Results and Provides 2025 Revenue Guidance - Defense World
Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $255,413 - Investing.com India
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - The Manila Times
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net - GlobeNewswire
Kiniksa's ARCALYST Soars 79% to $416M in 2024, Projects Strong 2025 Growth to $580M - StockTitan
Kiniksa Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $470k - Investing.com
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Acquired by Fmr LLC - Defense World
Kiniksa Pharmaceuticals CFO sells shares worth $593,997 By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals CFO sells shares worth $593,997 - Investing.com
Kiniksa Pharmaceuticals CFO sells shares worth $323,008 By Investing.com - Investing.com Canada
Kiniksa Pharmaceuticals CFO sells shares worth $323,008 - Investing.com India
KNSA (Kiniksa Pharmaceuticals International) Treasury Stock : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
Kiniksa Pharmaceuticals officer sells $194k in stock By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals officer sells $194k in stock - Investing.com India
Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com
Principal Financial Group Inc. Sells 14,100 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals COO sells shares valued at $357,680 By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals COO sells shares valued at $357,680 - Investing.com India
HHLR Advisors, Ltd. Reduces Stake in Kiniksa Pharmaceuticals Int - GuruFocus.com
Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025? - Insider Monkey
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference 2024 | KNSA Stock News - StockTitan
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewswire
10 Top Performing European Stocks Heading into 2025 - Insider Monkey
Kiniksa Pharmaceuticals International PLC (KNSA) Trading Down 3. - GuruFocus.com
Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earning - GuruFocus.com
Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ... - Yahoo Finance
Kiniksa Pharm's Revenue Surges 67% in Q3 - The Motley Fool
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):